Placebo-Controlled Single Dose Study to Evaluate Safety and Pharmacokinetics of GMI-1359 in Healthy Volunteers
Clinical trial NCT02931214 · COMPLETED
Trial details
- NCT number
- NCT02931214
- Sponsor
- GlycoMimetics Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2017-10-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.